<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, Feb. 16, 2018 (HealthDay News) — Many adolescent and young adult (AYA) cancer survivors are not receiving adequate follow-up care, according to a study presented at the American Society of Clinical Oncology’s annual Cancer Survivorship Symposium, held from Feb. 16 to 17 in Orlando, Fla.<\/p>\n
Lynda M. Beaupin, M.D., from the Roswell Park Cancer Institute in Buffalo, N.Y., and colleagues compared trends in follow-up among AYA cancer survivors. Data were obtained for two sets of survivors: 852 patients diagnosed between 2010 and 2014 (cohort A) and 783 patients diagnosed between 2005 and 2009 (cohort B).<\/p>\n
The researchers found that 2,367 AYAs were diagnosed between 2000 and 2015. Since 2015, 37 percent had no follow-up visit, with no significant variation seen across disease types. Overall, 33 and 48 percent of cohorts A and B, respectively, were not seen in 2016, regardless of insurance coverage. There was no correlation between follow-up status and disease type or insurance status.<\/p>\n
“Many adolescents and young adults are unaware of what their long-term risks are after they have finished their cancer treatment,” Beaupin said in a statement. “Doctors and other health care providers need to be more diligent in letting these patients know about future potential side-effects and health risks that could occur based on certain aspects of their cancer treatment.”<\/p>\n
One author disclosed financial ties to Spectrum Pharmaceuticals.<\/p>\n
Press Release<\/a><\/p>\n